India's Shilpa Medicare up after unit gets Australia approval
13/12/2023 03:57
** Shares of Shilpa Medicare SHME.NS rise 4.9% to 387.2
rupees
** The pharma co reported on Tuesday its unit received
approval from Therapeutic Goods Administration (TGA), Australia
to manufacture, label, pack and test medicinal oral mouth
dissolving films
** Stock trading above its 200-day simple moving average for
nearly 6 months
** Including session's gains, stock up 37% YTD
(Reporting by Ashna Teresa Britto in Bengaluru)
((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026